Journal article
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer
Cancer biology & therapy, Vol.16(4), pp.493-497
04/03/2015
DOI: 10.1080/15384047.2015.1017692
PMID: 25719413
Abstract
Bevacizumab and Tamoxifen are valid therapeutic options for metastatic breast cancer (mBC) patients. In this report, we describe a 47 year old woman with mBC successfully treated with a maintenance therapy with Bevacizumab+Tamoxifen. A maintenance approach using 2 different drugs with different targets and mechanism of action, such as anti-angiogenic and anti-hormonal treatment is particularly intriguing because they affect different pathways involved in mBC progression. Further studies including a large number of patients are needed, in order to select women who could benefit from this maintenance approach.
Details
- Title: Subtitle
- Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer
- Creators
- Giandomenico Roviello - University of SienaEdoardo Francini - Policlinico Umberto IArmando Perrella - University of SienaLetizia Laera - University of SienaMaria Antonietta Mazzei - University of SienaSusanna Guerrini - University of SienaFranco Roviello - University of SienaDaniele Marrelli - University of SienaRoberto Petrioli - University of Siena
- Resource Type
- Journal article
- Publication Details
- Cancer biology & therapy, Vol.16(4), pp.493-497
- DOI
- 10.1080/15384047.2015.1017692
- PMID
- 25719413
- ISSN
- 1538-4047
- eISSN
- 1555-8576
- Publisher
- Taylor & Francis
- Number of pages
- 5
- Language
- English
- Date published
- 04/03/2015
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985221145102771
Metrics
1 Record Views